ENTITY
Shenzhen Kangtai Biological Pr

Shenzhen Kangtai Biological Pr (300601 CH)

60
Analysis
Health CareChina
Shenzhen Kangtai Biological Products Co., Ltd. operates biological product manufacturing businesses. The Company produces biological vaccines and other vaccine products. Shenzhen Kangtai Biological Products conducts businesses in China.
more
bearishHKEX
19 Nov 2023 05:30

Index Rebalance & ETF Flow Recap: FRTIB, Japan, CSI300, CSI500, STAR50, WuXi XDC, Asahi

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
894 Views
Share
20 Jul 2023 19:49

Quiddity Primer for CSI 300/500 Index Rebalance Events

We evaluated the performance of 1205+ unique past Index rebalance cases (ADDs and DELs) involving the CSI 300 index and CSI 500 index from December...

Logo
1.1k Views
Share
17 Nov 2025 05:30

CSI A500 Index Rebalance Preview: Bunch of Changes to Lead to US$1.6bn Trade

There could be 23 changes for the CSI A500 Index at the Dec rebal. Estimated turnover is 2.9% and round-trip trade is US$1.6bn. Adds outperformed...

Logo
429 Views
Share
02 Dec 2024 15:42

Quiddity ChiNext/ChiNext 50 Dec 24 Results: ~80% Hit Rate; US$1bn+ One-Way Flows

We estimate US$851mn and US$191mn one-way flows for the ChiNext and ChiNext 50 December 2024 index rebal events respectively.

Share
02 Dec 2024 10:57

ChiNext/​​ChiNext 50 Index Rebalance: US$1.7bn Round-Trip Trade

There are 7 changes for the Chinext and 5 changes for the Chinext50. The round-trip trade across both indices is estimated to be CNY 12.24bn...

Logo
479 Views
Share
x